Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG
UP2024
Sponsor study identifier
interventional
370
1 country
1
Study Start
October 4, 2024
Actual (reported)Primary Completion
November 1, 2024
Actual (reported)Study Completion
November 1, 2024
Actual (reported)Small cutaneous ulcers are common in Papua New Guinea but are normally left untreated due to lack of easy access to basic medicines. The goal of this clinical trial is to test the efficacy of three readily available antibacterial plant medicines, Ficus septica, Pterocarpus indicus and Curcuma longa, comparing healing outcomes to control arms receiving Savlon antiseptic cream or no treatment. Participants with cutaneous ulcers less than 1cm in diameter will be randomized to receive topical treatment with one of three different plant medicines, Savlon cream or no treatment treatment and followed up at day 7 and 14 to assess ulcer healing and ulcer surface area.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 4, 2024
Actual (reported)November 1, 2024
Actual (reported)November 1, 2024
Actual (reported)November 14, 2024
Actual (reported)November 15, 2024
Actual (reported)Wound healing
A wound diameter reduction of more than 25% measured by the eKare wound imaging system.
2 weeks
F. septica sap contains the antibacterial alkaloid ficuseptine which exhibits activivity agaisnt S. pyogenes and H. ducreyi, two pàthogens associated with cutaneous ulcer disease in Papau New Guinea. The sap has been tested using the Ames test for mutagenesis, and found to be non-mutagenic; testing was carried out by toxicology service provider Gentronix, UK (results available separately on request).
Vunapope Hospital
Kokopo, EAST NEW Britan, Papua New Guinea
370 participants (actual enrollment reported by the registry).
First Submitted
November 14, 2024
First Posted
November 15, 2024
P. indicus sap exhibits antibacterial activivity agaisnt S. pyogenes, a pàthogen associated with cutaneous ulcer disease in Papau New Guinea. The sap has been tested using the Ames test for mutagenesis, and found to be non-mutagenic; testing was carried out by toxicology service provider Gentronix, UK (results available separately on request).
C. longa is a culinary herb that contains the antibatieral compound curcumin. Curcumin exhibits antibacterial activity agasint S. pyogenes and has profound effects on bacterial biofilms. This intervention uses a mulch of the rhizome that has been sqeeezed to produce a curcumin containing aqueous fluid.
Common over the counter antiseptic cream
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Start
October 4, 2024
Actual (reported)Primary Completion
November 1, 2024
Actual (reported)Study Completion
November 1, 2024
Actual (reported)Last Updated
November 29, 2024
Record last verified: 2024-11
Data will be made available upon request within a reasonable time-frame.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: